Wellbeing

Non-Hodgkin’s Lymphoma Advocacy, Education, and Support Groups

The following organizations provide a variety of support programs and educational materials for people with non-Hodgkin’s lymphoma and their family members, caregivers, and friends. However, this is not an endorsement of these organizations and the information they provide. You should always discuss any questions or concerns you have with your health care provider.

American Cancer Society

http://www.cancer.org

Toll-free information line: 1-800-ACS-2345

TTY: 1-866-228-4327

E-mail: http://www.cancer.org/asp/contactUs 

The American Cancer Society (ACS) is a national organization working to eliminate cancer as a major health problem through research, education, advocacy, and service. ACS operates the National Cancer Information Center, a call center that is available 24 hours a day, 7 days a week. The center answers questions about cancer, links callers with resources in their communities, and provides information on local events.

Leukemia and Lymphoma Society

http://www.leukemia-lymphoma.org

Phone: 1-800-955-4572

E-mail: http://www.leukemia-lymphoma.org/all

The Leukemia and Lymphoma Society is a voluntary health organization that funds cancer research and provides education and patient services related to leukemia, lymphoma, and other blood cancers. The society’s website offers decision tools for talking to your doctor and choosing a treatment center, a clinical trial service, treatment information booklets, fact sheets, and online discussion boards.

Lymphoma Research Foundation

http://www.lymphoma.org

Phone: 1-800-235-6848 (New York office) or 1-800-500-9976 (Los Angeles office)

The Lymphoma Research Foundation funds cutting-edge research to find a cure for lymphoma and provides programs and services for patients with lymphoma and their families that address treatment issues, research advances, and coping with all aspects of the disease. The foundation’s website offers an online guidebook on understanding non-Hodgkin’s lymphoma for patients, a peer-support program, a free helpline and information service, financial assistance, and patient stories.

National Cancer Institute

http://www.cancer.gov

Toll-free information line: 1-800-4-CANCER (1-800-422-6237)

TTY: 1-800-332-8615

LiveHelp: https://cissecure.nci.nih.gov/livehelp
 
E-mail: http://www.cancer.gov/contact 

The National Cancer Institute (NCI) is a federal agency and a component of the National Institutes of Health. NCI supports and conducts research, training, and education. NCI operates the Cancer Information Service, which answers questions about cancer by telephone, TTY, instant messaging (through the LiveHelp service), and e-mail. NCI’s website includes information about various cancer topics, research, and cancer statistics.

Patients Against Lymphoma

www.lymphomation.org

Patients Against Lymphoma provides support and evidence-based information, without health industry funding, to patients. The organization’s website offers patient stories, treatment tips, links to online support groups, advocacy tools and resources, and lists of lymphoma clinical trials.

This content was last modified on August 15, 2007 .

Latest Non-Hodgkin's Lymphoma News

  • May 14, 2008
    Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin's Lymphoma
    Patients diagnosed with non-Hodgkin’s lymphoma (NHL) who smoke tobacco products and/or drink large quantities of alcohol have a reduced chance of optimal survival. These results were recently published in the International Journal of Cancer.
  • May 8, 2008
    Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma
    Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease and have a worse prognosis than those with smaller masses. These findings were published in Lancet Oncology.
  • May 5, 2008
    Treanda® Included in NCCN Guidelines for CLL and NHL
    The chemotherapy agent Treanda® (bendamustine) has been added to the treatment guidelines of the National Comprehensive Cancer Network (NCCN) as an accepted treatment option for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL).
Select news items provided by Reuters Health
More Cancer News

Privacy Policy reviewed by TRUSTe

This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
Information:
verify here.

Secure transactions for this website use a thawte certificate to ensure secure transmission of your information.